Histone deacetylase 6 inhibition enhances oncolytic viral therapy
Tuesday, October 20, 2015 - 20:30
in Biology & Nature
Inhibition of histone deaceteylase 6 improves the ability of oncolytic herpes simplex virus type 1 to kill glioma cells, a new study indciates.